Medmen Enterprises (OTCMKTS:MMNFF)‘s stock had its “buy” rating reiterated by analysts at Seaport Global Securities in a note issued to investors on Monday, TipRanks reports. They presently have a $4.00 price objective on the stock.
Separately, Cowen started coverage on Medmen Enterprises in a research report on Friday, September 13th. They set an “underperform” rating on the stock.
Shares of MMNFF stock opened at $0.39 on Monday. Medmen Enterprises has a 1 year low of $0.36 and a 1 year high of $3.84. The business’s fifty day moving average is $0.84 and its 200-day moving average is $1.70.
MedMen Enterprises Inc, together with its subsidiaries, operates as a cannabis company in the United States. The company cultivates, produces, and distributes, and retails recreational and medicinal cannabis. As of November 1, 2018, it had licenses for 69 retail stores; and 17 cultivation and production facilities across 12 states.
Further Reading: Margin
Receive News & Ratings for Medmen Enterprises Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medmen Enterprises and related companies with MarketBeat.com's FREE daily email newsletter.